LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Galectin Therapeutics (NASDAQ: GALT)

Follow NASDAQ:GALT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ GALT Galectin Therapeutics
10X Fund, L.P. / 10 percent owner
10/22/2025
Sell
$4.93
20,000
$99K
5.90M
NASDAQ GALT Galectin Therapeutics
10X Fund, L.P. / 10 percent owner
10/22/2025
Sell
$4.94
30,000
$148K
5.87M
NASDAQ GALT Galectin Therapeutics
CALLICUTT JACK W / officer: Chief Financial Officer
09/12/2025
Buy
$1.37
8,706
$12K
16,320
NASDAQ GALT Galectin Therapeutics
CALLICUTT JACK W / officer: Chief Financial Officer
09/12/2025
Sell
$6.44
8,706
$56K
7,614
NASDAQ GALT Galectin Therapeutics
CALLICUTT JACK W / officer: Chief Financial Officer
09/12/2025
Sell
$1.37
8,706
$12K
0
NASDAQ GALT Galectin Therapeutics
LEWIS JOEL / director, officer: President and CEO
09/12/2025
Buy
$2.39
14,000
$33K
846,592
NASDAQ GALT Galectin Therapeutics
LEWIS JOEL / director, officer: President and CEO
09/12/2025
Sell
$6.36
14,000
$89K
832,592
NASDAQ GALT Galectin Therapeutics
LEWIS JOEL / director, officer: President and CEO
09/12/2025
Sell
$2.39
14,000
$33K
40,250

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous